Displaying drugs 13751 - 13775 of 14837 in total
Fe-Mesopone
Experimental
Implitapide
Implitapide is a microsomal triglyceride transfer protein (MTP)-inhibitor.
Investigational
Arimoclomol
Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.
Investigational
Pipendoxifene
ER modulator, ERA-923(Pipendoxifene) is a estrogen receptor modulator being evaluated for the treatment of breast cancer. Pipendoxifene is a new 2-phenyl indole selective estrogen receptor modulators (SERM )that exhibits an excellent preclinical pharmacological profile and was selected for further development as a treatment for metastatic breast cancer.
Investigational
Matched Description: … estrogen receptor modulators (SERM )that exhibits an excellent preclinical pharmacological profile and …
VX-702
VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). It acts as a p38 MAP kinase inhibitor. In the future, VX-702 may be investigated for combination with methotrexate, a commonly used therapy for RA.
Investigational
4-O-Demethylpenclomedine
Investigational
(R)-minalrestat
Experimental
5-Bromoindirubin
Experimental
2-heptyl-4-hydroxyquinoline N-oxide
Experimental
2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
Experimental
(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE
Experimental
Displaying drugs 13751 - 13775 of 14837 in total